Weiskirchen Ralf
Institute of Molecular Pathobiochemistry, Experimental Gene Therapy and Clinical Chemistry (IFMPEGKC), RWTH Aachen University Hospital, Pauwelsstr. 30, 52074, Aachen, Germany.
Res Integr Peer Rev. 2025 Jul 11;10(1):12. doi: 10.1186/s41073-025-00170-2.
Continuous cell lines are indispensable in basic and preclinical research. However, cross-contamination, misidentification, and over-passaging affect the validity and reproducibility of biomedical results. Although there have been efforts to highlight this problem for decades, definitive prevention remains a challenge. The International Cell Line Authentication Committee (ICLAC) registry (version 13, 26 April 2024) lists nearly 600 misidentified or contaminated cell lines. The inappropriate use of such cells has led to countless publications containing invalid data, creating a ripple effect of wasted resources, misleading follow-up studies, and compromised evidence-based conclusions.
The ICLAC registry was consulted to identify commonly misidentified cell lines. A literature search of PubMed was performed to identify recent papers using these lines in liver-related experiments. Four publications with questionable conclusions were highlighted, and the editors of the respective journals were informed with short comments or letters to the editor.
Reactions from journal editors varied widely. In two cases, the editors quickly published the comments, resulting in transparent corrections. In the third example, the editor conducted an internal investigation without immediately publishing a correction. In the fourth example, the journal declined to address concerns publicly.
Misidentified cell lines pose an ongoing threat to scientific rigor. Despite some responsible editorial interventions, the lack of universal standards fosters the dissemination of erroneous data. However, authors, reviewers, and editors have some important tools to prevent publications with misidentified cells by consulting available resources (e.g., ICLAC, Cellosaurus, Research Resource Identification Portal, SciScore™), and adopting consistent procedures to maintain research integrity.
连续细胞系在基础研究和临床前研究中不可或缺。然而,交叉污染、错误鉴定和过度传代会影响生物医学研究结果的有效性和可重复性。尽管数十年来一直在努力强调这个问题,但彻底预防仍然是一项挑战。国际细胞系认证委员会(ICLAC)登记册(2024年4月26日第13版)列出了近600种被错误鉴定或污染的细胞系。不当使用这些细胞导致了无数包含无效数据的出版物,产生了资源浪费、误导后续研究以及损害基于证据的结论的连锁反应。
查阅ICLAC登记册以识别常见的被错误鉴定的细胞系。在PubMed上进行文献检索,以识别最近在肝脏相关实验中使用这些细胞系的论文。突出显示了四篇结论存疑的出版物,并向各期刊的编辑发送了简短评论或致编辑信。
期刊编辑的反应差异很大。在两个案例中,编辑迅速发表了评论,从而进行了透明的更正。在第三个案例中,编辑进行了内部调查,但没有立即发表更正。在第四个案例中,该期刊拒绝公开回应相关问题。
被错误鉴定的细胞系对科学严谨性构成持续威胁。尽管有一些负责任的编辑干预措施,但缺乏通用标准助长了错误数据的传播。然而,作者、审稿人和编辑有一些重要工具来防止发表使用被错误鉴定细胞的文章,即查阅可用资源(如ICLAC、细胞osaurus、研究资源识别门户、SciScore™),并采用一致的程序来维护研究诚信。